Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine vs Alkylating Agent in Metastatic Breast Cancer
NCT01091168Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2009
- Primary completion
- Aug 2012
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of vinflunine in breast cancer, sponsored by Pierre Fabre Laboratories. Started Jul 2009; status: completed.
02
Drugs
vinflunine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01091168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091168.